206 related articles for article (PubMed ID: 19553566)
21. Inhibitory effect of sulphated polysaccharide porphyran on nitric oxide production in lipopolysaccharide-stimulated RAW264.7 macrophages.
Jiang Z; Hama Y; Yamaguchi K; Oda T
J Biochem; 2012 Jan; 151(1):65-74. PubMed ID: 21976706
[TBL] [Abstract][Full Text] [Related]
22. SM905, an artemisinin derivative, inhibited NO and pro-inflammatory cytokine production by suppressing MAPK and NF-kappaB pathways in RAW 264.7 macrophages.
Wang JX; Hou LF; Yang Y; Tang W; Li Y; Zuo JP
Acta Pharmacol Sin; 2009 Oct; 30(10):1428-35. PubMed ID: 19801997
[TBL] [Abstract][Full Text] [Related]
23. Presence of excess tetrahydrobiopterin during nitric oxide production from inducible nitric oxide synthase in LPS-treated rat aorta.
Shimizu S; Ishii M; Kawakami Y; Kiuchi Y; Momose K; Yamamoto T
Life Sci; 1999; 65(26):2769-79. PubMed ID: 10622266
[TBL] [Abstract][Full Text] [Related]
24. Eriobotryae folium extract suppresses LPS-induced iNOS and COX-2 expression by inhibition of NF-kappaB and MAPK activation in murine macrophages.
Uto T; Suangkaew N; Morinaga O; Kariyazono H; Oiso S; Shoyama Y
Am J Chin Med; 2010; 38(5):985-94. PubMed ID: 20821828
[TBL] [Abstract][Full Text] [Related]
25. p38 but not p44/42 mitogen-activated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 macrophages.
Chen CC; Wang JK
Mol Pharmacol; 1999 Mar; 55(3):481-8. PubMed ID: 10051531
[TBL] [Abstract][Full Text] [Related]
26. Xanthotoxin suppresses LPS-induced expression of iNOS, COX-2, TNF-α, and IL-6 via AP-1, NF-κB, and JAK-STAT inactivation in RAW 264.7 macrophages.
Lee SB; Lee WS; Shin JS; Jang DS; Lee KT
Int Immunopharmacol; 2017 Aug; 49():21-29. PubMed ID: 28550731
[TBL] [Abstract][Full Text] [Related]
27. Compound FLZ inhibits lipopolysaccharide-induced inflammatory effects via down-regulation of the TAK-IKK and TAK-JNK/p38MAPK pathways in RAW264.7 macrophages.
Pang HY; Liu G; Liu GT
Acta Pharmacol Sin; 2009 Feb; 30(2):209-18. PubMed ID: 19169268
[TBL] [Abstract][Full Text] [Related]
28. Regulation of lipopolysaccharide-induced inducible nitric-oxide synthase expression through the nuclear factor-kappaB pathway and interferon-beta/tyrosine kinase 2/Janus tyrosine kinase 2-signal transducer and activator of transcription-1 signaling cascades by 2-naphthylethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (THI 53), a new synthetic isoquinoline alkaloid.
Kim HJ; Tsoyi K; Heo JM; Kang YJ; Park MK; Lee YS; Lee JH; Seo HG; Yun-Choi HS; Chang KC
J Pharmacol Exp Ther; 2007 Feb; 320(2):782-9. PubMed ID: 17108235
[TBL] [Abstract][Full Text] [Related]
29. Sulfuretin isolated from heartwood of Rhus verniciflua inhibits LPS-induced inducible nitric oxide synthase, cyclooxygenase-2, and pro-inflammatory cytokines expression via the down-regulation of NF-kappaB in RAW 264.7 murine macrophage cells.
Shin JS; Park YM; Choi JH; Park HJ; Shin MC; Lee YS; Lee KT
Int Immunopharmacol; 2010 Aug; 10(8):943-50. PubMed ID: 20546946
[TBL] [Abstract][Full Text] [Related]
30. IVSE, isolated from Inula japonica,suppresses LPS-induced NO production via NF-κB and MAPK inactivation in RAW264.7 cells.
Chen X; Tang SA; Lee E; Qiu Y; Wang R; Duan HQ; Dan S; Jin M; Kong D
Life Sci; 2015 Mar; 124():8-15. PubMed ID: 25625245
[TBL] [Abstract][Full Text] [Related]
31. Estrogen attenuates lipopolysaccharide-induced nitric oxide production in macrophages partially via the nongenomic pathway.
Liu L; Wang Z
Cell Immunol; 2013; 286(1-2):53-8. PubMed ID: 24321566
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of caspase 3 abrogates lipopolysaccharide-induced nitric oxide production by preventing activation of NF-kappaB and c-Jun NH2-terminal kinase/stress-activated protein kinase in RAW 264.7 murine macrophage cells.
Chakravortty D; Kato Y; Sugiyama T; Koide N; Mu MM; Yoshida T; Yokochi T
Infect Immun; 2001 Mar; 69(3):1315-21. PubMed ID: 11179293
[TBL] [Abstract][Full Text] [Related]
33. Caffeoyloxy-5,6-dihydro-4-methyl-(2H)-pyran-2-one isolated from the leaves of Olinia usambarensis attenuates LPS-induced inflammatory mediators by inactivating AP-1 and NF-κB.
Kang SY; Shin JS; Kim SY; Noh YS; Lee SJ; Hwang H; Deyou T; Jang YP; Lee KT
Chem Biol Interact; 2019 Aug; 309():108718. PubMed ID: 31211952
[TBL] [Abstract][Full Text] [Related]
34. Isobutyrylshikonin inhibits lipopolysaccharide-induced nitric oxide and prostaglandin E2 production in BV2 microglial cells by suppressing the PI3K/Akt-mediated nuclear transcription factor-κB pathway.
Jayasooriya RG; Lee KT; Kang CH; Dilshara MG; Lee HJ; Choi YH; Choi IW; Kim GY
Nutr Res; 2014 Dec; 34(12):1111-9. PubMed ID: 25454762
[TBL] [Abstract][Full Text] [Related]
35. A phenolic acid phenethyl urea compound inhibits lipopolysaccharide-induced production of nitric oxide and pro-inflammatory cytokines in cell culture.
Hwang JM; Yu JY; Jang YO; Kim BT; Hwang KJ; Jeon YM; Lee JC
Int Immunopharmacol; 2010 Apr; 10(4):526-32. PubMed ID: 20138247
[TBL] [Abstract][Full Text] [Related]
36. Roxatidine suppresses inflammatory responses via inhibition of NF-κB and p38 MAPK activation in LPS-induced RAW 264.7 macrophages.
Cho EJ; An HJ; Shin JS; Choi HE; Ko J; Cho YW; Kim HM; Choi JH; Lee KT
J Cell Biochem; 2011 Dec; 112(12):3648-59. PubMed ID: 21809375
[TBL] [Abstract][Full Text] [Related]
37. Eugenolol and glyceryl-isoeugenol suppress LPS-induced iNOS expression by down-regulating NF-kappaB AND AP-1 through inhibition of MAPKS and AKT/IkappaBalpha signaling pathways in macrophages.
Yeh JL; Hsu JH; Hong YS; Wu JR; Liang JC; Wu BN; Chen IJ; Liou SF
Int J Immunopathol Pharmacol; 2011; 24(2):345-56. PubMed ID: 21658309
[TBL] [Abstract][Full Text] [Related]
38. 3β-Angeloyloxy-8β,10β-dihydroxyeremophila-7(11)-en-12,8α-lactone Inhibits Lipopolysaccharide-Induced Nitric Oxide Production in RAW264.7 Cells.
Sun X; Jiang C; Ma L; Zhao X; Chang J; Zheng B; Li L; Xie W; Li X
Biol Pharm Bull; 2015; 38(6):836-43. PubMed ID: 26027823
[TBL] [Abstract][Full Text] [Related]
39. Subtilase cytotoxin enhances Escherichia coli survival in macrophages by suppression of nitric oxide production through the inhibition of NF-κB activation.
Tsutsuki H; Yahiro K; Suzuki K; Suto A; Ogura K; Nagasawa S; Ihara H; Shimizu T; Nakajima H; Moss J; Noda M
Infect Immun; 2012 Nov; 80(11):3939-51. PubMed ID: 22949549
[TBL] [Abstract][Full Text] [Related]
40. Fraxinellone inhibits lipopolysaccharide-induced inducible nitric oxide synthase and cyclooxygenase-2 expression by negatively regulating nuclear factor-kappa B in RAW 264.7 macrophages cells.
Kim JH; Park YM; Shin JS; Park SJ; Choi JH; Jung HJ; Park HJ; Lee KT
Biol Pharm Bull; 2009 Jun; 32(6):1062-8. PubMed ID: 19483316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
